Literature DB >> 32381037

Correction to: Update on the EFFECTS study of fluoxetine for stroke recovery: a randomised controlled trial in Sweden.

Erik Lundström1,2, Eva Isaksson3, Per Näsman4, Per Wester5,6, Björn Mårtensson7, Bo Norrving8, Håkan Wallén9, Jörgen Borg5, Martin Dennis10, Gillian Mead10, Graeme J Hankey11, Maree L Hackett12,13, Katharina S Sunnerhagen14,15,16,17.   

Abstract

Following publication of the original article [1], we were notified that one of the corresponding author's affiliations was omitted.

Entities:  

Year:  2020        PMID： 32381037      PMCID： PMC7203841          DOI： 10.1186/s13063-020-04327-w

Source DB:  PubMed          Journal:  Trials        ISSN： 1745-6215            Impact factor:   2.279


Correction to: Trials (2020) 21:233 https://doi.org/10.1186/s13063-020-4124-7 Following publication of the original article [1], we were notified that one of the corresponding author’s affiliations was omitted. Affiliation no. 2 is now added to for Prof. Erik Lundström.
  1 in total

Review 1.  Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery.

Authors:  Lynn A Legg; Ann-Sofie Rudberg; Xing Hua; Simiao Wu; Maree L Hackett; Russel Tilney; Linnea Lindgren; Mansur A Kutlubaev; Cheng-Fang Hsieh; Amanda J Barugh; Graeme J Hankey; Erik Lundström; Martin Dennis; Gillian E Mead
Journal:  Cochrane Database Syst Rev       Date:  2021-11-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.